2021-01-05,Millendo Therapeutics Provides Pipeline and Business Update
2020-12-10,Is MLND A Good Stock To Buy Now?
2020-11-09,Millendo Therapeutics Reports Third Quarter 2020 Operating and Financial Results
2020-10-26,Millendo Therapeutics (NASDAQ:MLND) Will Have To Spend Its Cash Wisely
2020-09-24,"Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist"
2020-09-03,Millendo Therapeutics to Participate in September Investor Conferences
2020-08-10,Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results
2020-08-05,Millendo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
2020-07-02,"Millendo Therapeutics, Inc. (MLND): Hedge Funds Were Caught Flatfooted"
2020-06-23,Millendo Therapeutics Provides Corporate and Pipeline Update
2020-06-16,Billionaire Ken Griffin Pulls the Trigger on These 3 Penny Stocks
2020-06-01,Is the Options Market Predicting a Spike in Millendo (MLND) Stock?
2020-05-08,Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results
2020-04-29,Here's Why We're A Bit Worried About Millendo Therapeutics's (NASDAQ:MLND) Cash Burn Situation
2020-04-06,Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS)
2020-03-11,Millendo Therapeutics Reports Full Year 2019 Operating and Financial Results
2020-03-05,Millendo Therapeutics to Present at Upcoming Investor Conferences
2020-02-18,Millendo Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
2020-02-10,"Millendo Therapeutics Appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer"
2020-01-15,Will Millendo Continue to Surge Higher?
2020-01-09,Millendo Therapeutics Promotes Thomas Hoover to Chief Commercial Officer
2019-12-24,"Millendo Therapeutics, Inc. (MLND): Hedge Funds In Wait-and-See Mode"
2019-12-19,Geoff Nichol Appointed to Millendo Therapeutics Board of Directors
2019-12-05,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission"
2019-12-04,Millendo Therapeutics Announces Pricing of Public Offering of Common Stock
2019-12-04,Millendo Therapeutics Announces Proposed Public Offering of Common Stock
2019-11-13,Millendo Therapeutics Reports Third Quarter 2019 Operating and Financial Results
2019-11-13,Millendo Therapeutics Completes Patient Recruitment for Pivotal Study of Livoletide in Prader-Willi Syndrome
2019-11-11,Millendo Therapeutics to Present at the Stifel 2019 Healthcare Conference
2019-11-07,"Millendo Therapeutics to Host Prader-Willi Syndrome (PWS) Breakfast Symposium on Thursday, November 14, 2019"
2019-11-01,We Think Millendo Therapeutics (NASDAQ:MLND) Needs To Drive Business Growth Carefully
2019-10-03,"The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo"
2019-09-26,Millendo Therapeutics to Present at Prader-Willi Syndrome Conferences
2019-08-29,Millendo Therapeutics to Participate in September Investor Conferences
2019-08-20,Millendo Therapeutics Appoints Tamara Joseph as General Counsel and Ryan Zeidan as Chief Development Officer
2019-08-12,Millendo Therapeutics Reports Second Quarter 2019 Operating and Financial Results
2019-07-19,"Millendo's Lead Asset Could Address Unmet PWS Need, Wedbush Says"
2019-07-04,"Hedge Funds Have Never Been This Bullish On Millendo Therapeutics, Inc.  (MLND)"
2019-06-18,Millendo Therapeutics Announces Departure of Chief Medical Officer
2019-05-26,"How Many Millendo Therapeutics, Inc. (NASDAQ:MLND) Shares Do Institutions Own?"
2019-05-23,Millendo Therapeutics to Present at Jefferies 2019 Healthcare Conference
2019-05-15,Millendo Therapeutics Reports First Quarter 2019 Operating and Financial Results
2019-05-08,Millendo Therapeutics Announces 21st European Congress of Endocrinology 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classic Congenital Adrenal Hyperplasia
2019-05-02,Millendo Therapeutics to Participate in May Investor Conferences
2019-04-24,Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2019-04-03,Will OvaScience Continue to Surge Higher?
2019-04-02,"Millendo Therapeutics, Inc. to Present at the 18th Annual Needham Healthcare Conference"
2019-03-29,Millendo Reports Full Year 2018 Operating and Financial Results
2019-03-20,"The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company"
2019-03-19,Millendo Therapeutics Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome
2019-03-14,Millendo Therapeutics Announces ENDO 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classic Congenital Adrenal Hyperplasia
2019-03-04,"Millendo Therapeutics, Inc. to Present at the Cowen and Company 39th Annual Healthcare Conference and the Oppenheimer 29th Annual Healthcare Conference"
2019-02-21,"Millendo Therapeutics, Inc. to Present at the 8th Annual SVB Leerink Global Healthcare Conference"
2019-02-01,Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2019-01-17,Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
